Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis - Related Studies

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

This study has been completed.

Study NCT00027300. Last updated on June 7, 2006. Information provided by Biogen Idec

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Multiple Sclerosis
		Multiple Sclerosis, Relapsing-Remitting
		Sclerosis

2	More general conditions related to this trial
		Autoimmune Diseases
		Autoimmune Diseases of the Nervous System
		Demyelinating Autoimmune Diseases, CNS
		Demyelinating Diseases
		Immune System Diseases
		Nervous System Diseases
		Pathologic Processes

3	Interventions listed in this trial
		Natalizumab

4	Sponsors listed in this trial
		Biogen Idec
		Elan Pharmaceuticals